ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

AGLE Aeglea BioTherapeutics Inc

12.01
0.00 (0.00%)
02 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Aeglea BioTherapeutics Inc AGLE 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.00 0.00% 12.01 09:00:00
개장가 저가 고가 종가 전일 종가
12.01 12.01
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
30/04/202413:15EDGAR2Form EFFECT - Notice of Effectiveness
26/04/202405:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/04/202405:40EDGAR2Form SC 13D/A - General statement of acquisition of..
26/04/202405:21EDGAR2Form 8-K - Current report
02/04/202405:06EDGAR2Form DEF 14A - Other definitive proxy statements
20/03/202420:14EDGAR2Form PRE 14A - Other preliminary proxy statements
19/03/202405:06EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
18/03/202421:31EDGAR2Form 8-K - Current report
15/03/202405:12EDGAR2Form POS AM - Post-Effective amendments for registration..
29/11/202306:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/11/202321:33EDGAR2Form 8-K - Current report
28/11/202306:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/11/202306:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/11/202306:32EDGAR2Form 3 - Initial statement of beneficial ownership of..
28/11/202306:27EDGAR2Form 3 - Initial statement of beneficial ownership of..
28/11/202306:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202322:30PRNUSAeglea BioTherapeutics Announces Name Change to Spyre..
23/11/202310:45EDGAR2Form 8-K - Current report
23/11/202307:00PRNUSAeglea BioTherapeutics Announces Grants of Inducement Awards
16/11/202307:18EDGAR2Form S-1/A - General form for registration of securities..
16/11/202307:14EDGAR2Form 8-K - Current report
15/11/202305:13EDGAR2Form SC 13G - Statement of acquisition of beneficial..
10/11/202306:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/11/202306:06EDGAR2Form 8-K - Current report
10/11/202306:05PRNUSAeglea BioTherapeutics Reports Third Quarter 2023 Financial..
04/11/202306:00PRNUSAeglea BioTherapeutics Announces Grants of Inducement Awards
31/10/202309:00PRNUSAeglea BioTherapeutics to Participate in Upcoming November..
27/10/202310:53EDGAR2Form DEF 14A - Other definitive proxy statements
24/10/202322:00EDGAR2Form 8-K - Current report
07/10/202310:40EDGAR2Form PRER14A - Preliminary Proxy Soliciting materials
06/10/202306:13EDGAR2Form 8-K - Current report
03/10/202307:02PRNUSAeglea BioTherapeutics Announces Grants of Inducement Awards
26/09/202305:02EDGAR2Form 8-K - Current report
15/09/202306:03PRNUSAeglea BioTherapeutics to Participate in Upcoming September..
09/09/202306:05EDGAR2Form 8-K - Current report
07/09/202321:40PRNUSAeglea BioTherapeutics Announces Reverse Stock Split
06/09/202305:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/09/202305:10EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/09/202305:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/09/202305:06EDGAR2Form 3 - Initial statement of beneficial ownership of..
05/09/202320:06EDGAR2Form 8-K - Current report
05/09/202320:00PRNUSAeglea BioTherapeutics Expands Executive Leadership Team..
11/08/202320:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/08/202320:02EDGAR2Form 8-K - Current report
11/08/202320:01EDGAR2Form 8-K - Current report
11/08/202320:00PRNUSAeglea BioTherapeutics Reports Second Quarter 2023 Financial..
08/08/202310:51EDGAR2Form PRE 14A - Other preliminary proxy statements
08/08/202305:25EDGAR2Form S-3 - Registration statement under Securities Act of..
28/07/202322:01EDGAR2Form SC 13G - Statement of acquisition of beneficial..
27/07/202320:01EDGAR2Form 8-K - Current report

최근 히스토리

Delayed Upgrade Clock